Nifty
Sensex
:
:
8412.80
27288.17
12.45(0.15%)
50.11(0.18%)

Chemicals

Rating :
76/99   (View)

BSE: 530019 | NSE: JUBILANT

692.05
19.30 (2.87%)
16-Jan-2017 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 667.00
  • 697.00
  • 658.00
  • 672.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 1666059
  • 11529.96
  • 752.00
  • 275.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,727.58
  • 21.72
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,899.82
  • 0.45%
  • 3.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.02%
  • 3.56%
  • 11.72%
  • FII
  • DII
  • Others
  • 0.11%
  • 6.54%
  • 24.05%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Mar 16
Mar 15
Var%
Dec 15
Dec 14
Var%
Net Sales
1,385.50
1,463.05
-5.30%
1,419.53
1,458.55
-2.68%
1,501.27
1,536.54
-2.30%
1,379.45
1,445.48
-4.57%
Expenses
1,045.17
1,142.47
-8.52%
1,051.37
1,132.88
-7.19%
1,183.31
1,295.30
-8.65%
1,074.44
1,270.41
-15.43%
EBITDA
340.33
320.58
6.16%
368.16
325.67
13.05%
317.96
241.24
31.80%
305.01
175.07
74.22%
EBIDTM
23.98%
21.91%
25.94%
22.33%
21.18%
15.70%
22.11%
12.11%
Other Income
4.92
4.47
10.07%
4.29
3.80
12.89%
2.52
5.83
-56.78%
2.85
6.05
-52.89%
Interest
79.96
97.42
-17.92%
82.77
92.65
-10.66%
89.93
79.20
13.55%
90.01
85.82
4.88%
Depreciation
72.01
75.10
-4.11%
71.52
70.21
1.87%
126.02
66.21
90.33%
74.65
79.51
-6.11%
PBT
193.43
154.84
24.92%
218.26
168.55
29.49%
120.99
67.79
78.48%
139.96
15.60
797.18%
Tax
49.72
39.02
27.42%
54.24
40.49
33.96%
50.31
25.06
100.76%
23.03
20.22
13.90%
PAT
143.71
115.82
24.08%
164.02
128.06
28.08%
70.68
42.73
65.41%
116.93
-4.62
-
PATM
10.13%
7.92%
11.55%
8.78%
4.71%
2.78%
8.48%
-0.32%
EPS
9.31
7.27
28.06%
10.14
8.04
26.12%
4.44
2.68
65.67%
7.34
-0.70
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
5,802.32
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
2,488.34
1,808.87
Net Sales Growth
-0.41%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
41.38%
37.56%
 
Cost Of Goods Sold
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
986.26
830.33
Gross Profit
3,686.13
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
1,502.08
978.54
GP Margin
63.53%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
60.36%
54.10%
Total Expenditure
4,513.72
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
2,034.35
1,546.77
Power & Fuel Cost
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
170.43
130.48
% Of Sales
6.32%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
6.85%
7.21%
Employee Cost
1,126.73
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
375.71
211.26
% Of Sales
19.42%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
15.10%
11.68%
Manufacturing Exp.
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
230.80
169.05
% Of Sales
7.52%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
9.28%
9.35%
General & Admin Exp.
256.56
302.28
264.23
208.35
200.72
195.72
196.68
191.38
137.43
102.35
% Of Sales
4.42%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
5.52%
5.66%
Selling & Distn. Exp.
189.08
203.98
160.04
123.28
111.85
90.92
125.97
124.22
107.56
91.16
% Of Sales
3.26%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
4.32%
5.04%
Miscellaneous Exp.
21.98
39.72
19.59
23.53
28.50
27.21
46.18
26.41
26.15
91.16
% Of Sales
0.38%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
1.05%
0.67%
EBITDA
1,288.60
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
453.99
262.10
EBITDA Margin
22.21%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
18.24%
14.49%
Other Income
13.64
42.45
19.06
29.87
31.48
17.24
118.09
106.66
144.41
125.95
Interest
389.40
367.61
337.11
310.93
238.23
119.99
155.57
330.09
38.36
30.46
Depreciation
345.98
287.95
281.17
253.79
220.65
180.10
124.68
163.24
103.91
62.29
PBT
566.87
88.43
421.78
533.29
462.79
282.02
517.90
296.58
456.13
295.30
Tax
152.85
80.48
69.64
152.36
68.41
13.37
95.94
26.72
57.28
71.25
Tax Rate
26.16%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
12.56%
24.13%
PAT
431.49
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
400.50
228.00
PAT before Minority Interest
431.49
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
398.85
224.06
Minority Interest
0.00
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
1.65
3.94
PAT Margin
7.44%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
16.10%
12.60%
PAT Growth
847.04%
-152.97%
-28.61%
948.97%
-93.66%
-45.49%
48.83%
-29.29%
75.66%
 
Unadjusted EPS
27.09
-3.63
6.85
9.59
0.91
14.42
28.56
19.22
27.28
15.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
2,909.57
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
1,256.20
906.13
Share Capital
15.93
15.93
15.45
15.93
15.93
15.93
15.88
14.76
14.62
14.35
Total Reserves
2,893.64
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
1,241.50
891.76
Non-Current Liabilities
3,522.97
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
2,238.68
1,788.63
Secured Loans
2,646.48
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
1,058.59
417.17
Unsecured Loans
397.50
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
1,049.87
1,235.44
Long Term Provisions
70.46
67.04
219.53
237.96
169.70
39.87
0.00
0.00
0.00
0.00
Current Liabilities
2,514.48
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
667.91
524.81
Trade Payables
599.64
721.19
718.14
647.13
836.98
517.43
688.83
584.06
306.65
254.59
Other Current Liabilities
977.21
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
65.14
37.19
Short Term Borrowings
728.19
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
0.00
0.00
Short Term Provisions
209.44
97.49
257.25
101.84
109.18
403.28
466.59
457.85
296.13
233.03
Total Liabilities
8,947.02
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
4,184.18
3,236.98
Net Block
5,091.40
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
1,912.42
1,227.90
Gross Block
7,861.87
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
2,495.91
1,667.15
Accumulated Depreciation
2,770.47
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
583.49
439.25
Non Current Assets
6,045.70
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
2,402.01
1,464.45
Capital Work in Progress
593.56
596.60
472.39
436.89
685.55
666.71
505.63
503.12
484.69
235.69
Non Current Investment
36.11
39.50
33.99
25.61
19.20
32.75
32.70
33.22
4.90
0.87
Long Term Loans & Adv.
293.32
327.17
328.42
379.47
299.86
249.18
0.00
0.00
0.00
0.00
Other Non Current Assets
31.30
29.68
2.21
0.37
0.79
0.55
0.00
0.00
0.00
0.00
Current Assets
2,901.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
1,780.52
1,768.45
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
40.73
3.02
Inventories
1,216.06
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
434.97
353.24
Sundry Debtors
929.73
819.27
805.87
708.54
652.69
520.45
518.61
504.41
425.78
294.81
Cash & Bank
344.48
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
523.77
874.91
Other Current Assets
411.05
265.59
301.21
380.29
357.59
334.88
518.27
485.49
355.27
242.47
Short Term Loans & Adv.
246.93
144.56
136.04
182.01
256.70
217.50
498.14
444.09
323.54
228.91
Net Current Assets
386.84
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
1,112.61
1,243.64
Total Assets
8,947.02
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08
4,184.18
3,236.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
1,092.30
783.26
772.27
969.90
707.17
389.75
709.61
558.06
257.47
190.64
PBT
584.34
40.32
207.28
341.14
114.11
240.59
517.90
296.58
456.13
295.30
Adjustment
702.67
725.84
756.60
752.36
795.44
318.42
189.22
352.94
34.70
7.55
Changes in Working Capital
-146.64
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
-185.10
-88.62
Cash after chg. in Working capital
1,140.37
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
305.73
214.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
-45.42
-35.57
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-326.45
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
-1,139.35
-367.49
Net Fixed Assets
-59.56
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
-281.91
-251.03
Net Investments
59.43
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
-102.45
-1,034.27
Others
-326.32
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
-754.99
917.81
Cash from Financing Activity
-822.33
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
592.81
962.95
Net Cash Inflow / Outflow
-56.48
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
-289.08
786.10
Opening Cash & Equivalents
391.63
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
874.91
138.96
Closing Cash & Equivalent
339.17
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89
523.82
874.93

Financial Ratios

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
182.67
154.04
170.07
155.46
141.70
136.38
137.88
85.89
85.81
62.88
ROA
4.91%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
10.75%
8.47%
ROE
16.09%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
36.99%
25.98%
ROCE
13.27%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
16.71%
15.89%
Fixed Asset Turnover
0.78
0.81
0.84
0.82
0.78
0.70
0.82
1.02
1.26
1.27
Receivable days
53.68
49.56
46.53
47.00
48.71
53.83
48.18
46.63
50.03
50.97
Inventory Days
75.23
78.58
75.51
73.76
71.07
71.61
60.59
51.66
54.72
62.44
Payable days
52.31
52.17
51.42
45.33
38.70
50.95
58.42
49.77
49.78
50.27
Cash Conversion Cycle
76.60
75.98
70.61
75.42
81.08
74.50
50.34
48.52
54.97
63.14
Total Debt/Equity
1.55
1.95
1.67
1.71
1.69
1.81
1.45
3.11
1.68
1.83
Interest Cover
2.50
1.11
1.61
2.10
1.48
3.01
4.33
1.90
12.89
10.70

News Update


  • Jubilant Life Sciences issues Commercial Papers worth Rs 50 crore
    11th January 2017

    The tenure of the instrument is 70 days and allotted on January 11, 2017

    Read More
  • Jubilant Life Sciences issues Commercial Papers worth Rs 50 crore
    6th January 2017

    The tenure of the instrument is 61 days and allotted on January 5, 2017

    Read More
  • Jubilant Life Sciences’ arm inks long term contracts in Radiopharma business
    4th January 2017

    Jubilant Pharma, through one of its units JDI, has signed long term contracts with distribution networks in the US

    Read More
  • Jubilant Life Sciences hikes prices of certain intermediates upto 15%
    20th December 2016

    The company has increased price for Beta Picoline, 3-Cyanopyridine and Vitamin B3

    Read More
  • Jubilant Life Sciences plans to raise Rs 1,000 crore via NCDs
    28th November 2016

    Approval to the board to raise the amount also stipulates that this could be done in one or more series/tranches

    Read More
  • Jubilant Life Sciences issues commercial papers amounting Rs 50 crore
    10th November 2016

    The aggregate amount of Commercial Papers outstanding as on date is Rs 100 crore

    Read More
  • Jubilant Life Sciences receives ANDA approval for Rosuvastatin Calcium Tablets
    1st November 2016

    The company had a total of 72 ANDAs for Oral Solids filed in the US, of which 47 have been approved

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.